Tag: <span>disease-oriented dosing</span>

Home / disease-oriented dosing
Towards disease-oriented dosing of rapamycin for longevity
Post

Towards disease-oriented dosing of rapamycin for longevity

by Impact Journals LLC Relations between aging and age-related diseases (ARDs). Credit: Aging (2023). DOI: 10.18632/aging.204920 A new research perspective titled “Towards disease-oriented dosing of rapamycin for longevity: does aging exist or only age-related diseases?” has been published in Aging. In his new research perspective, Dr. Mikhail V. Blagosklonny from Roswell Park Comprehensive Cancer Center discusses aging and rapamycin (Sirolimus)—the only drug...